(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are ADOCIA, BARCO, and BELYSSE GROUP.

Financial Asset	Price	Change	Updated (EST)
ADOCIA (ADOC.PA)	6.67	17.57%	2024-07-17 12:45:13
BARCO (BAR.BR)	11.91	9.97%	2024-07-17 12:05:16
BELYSSE GROUP (BELYS.BR)	0.85	6.96%	2024-07-17 12:05:28
ELLIPTIC LABORATOR (ELABS.OL)	13.44	5.99%	2024-07-17 12:25:50
OKEA (OKEA.OL)	23.78	5.69%	2024-07-17 12:42:02
BEWI (BEWI.OL)	27.30	5.41%	2024-07-17 12:25:06
BERGENBIO (BGBIO.OL)	12.68	5.09%	2024-07-17 12:25:04
NOVABASE,SGPS (NBA.LS)	6.00	4.35%	2024-07-17 12:23:45
ATOS (ATO.PA)	1.16	4.23%	2024-07-17 12:46:15
VOW (VOW.OL)	7.59	4.12%	2024-07-17 12:44:28

The three biggest losers today are COFINA,SGPS, NEL, and ASML HOLDING.

Financial Asset	Price	Change	Updated (EST)
COFINA,SGPS (CFN.LS)	0.65	-14.88%	2024-07-17 12:23:05
NEL (NEL.OL)	6.21	-8.43%	2024-07-17 12:41:28
ASML HOLDING (ASML.AS)	895.90	-8.38%	2024-07-17 12:00:37
ATLANTIC SAPPHIRE (ASA.OL)	4.75	-6.22%	2024-07-17 12:24:48
SALMONES CAMANCHAC (SACAM.OL)	21.80	-6.03%	2024-07-17 12:42:52
ASM INTERNATIONAL (ASM.AS)	693.60	-5.61%	2024-07-17 12:00:35
VIVORYON (VVY.AS)	2.08	-5.03%	2024-07-17 12:04:42
INTEROIL EXPL PROD (IOX.OL)	4.91	-4.96%	2024-07-17 12:40:40
EBUSCO HOLDING (EBUS.AS)	1.35	-4.93%	2024-07-17 12:01:47
HOLLAND COLOURS (HOLCO.AS)	90.00	-4.76%	2024-07-17 12:02:34

Winners today

1. ADOCIA (ADOC.PA)

17.57% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA jumping 17.57% to €6.67 on Wednesday, following the last session’s upward trend. CAC 40 fell 0.12% to €7,570.81, after two sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-1.9.

Volume

Today’s last reported volume for ADOCIA is 410219 which is 260.23% above its average volume of 113877.

Revenue Growth

Year-on-year quarterly revenue growth declined by 62.6%, now sitting on 10.84M for the twelve trailing months.

More news about ADOCIA.

2. BARCO (BAR.BR)

9.97% Price Change

Barco NV, together with its subsidiaries, develops visualization solutions for the entertainment, enterprise, and healthcare markets in the Americas, Europe, Middle East, Africa, and the Asia-Pacific. It operates through three divisions: Entertainment, Enterprise, and Healthcare. The company offers medical displays, including radiology, dental, breast imaging, surgical, clinical review, custom medical, digital pathology, and all-in-one displays; medical display controllers; healthcare software; digital operating room solutions, such as medical device management and surgical collaboration; rear-projection, LED, and LCD video walls, as well as video wall controllers; and wireless conferencing and presentation systems, as well as video bars for wireless collaboration. It also provides projection products, comprising cinema, home cinema, installation, rental, and simulation; immersive systems consisting of power walls, canvas, and caves; control room software, including Barco CTRL, SecureStream, OpSpace, and transForm N/CMS; image processing products, such as screen management and Event Master; and support, maintenance, training, and professional services. Barco NV was founded in 1934 and is headquartered in Kortrijk, Belgium.

BEL 20 ended the session with BARCO jumping 9.97% to €11.91 on Wednesday, following the last session’s upward trend. BEL 20 jumped 0.28% to €4,017.59, after two successive sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, BARCO has a trailing twelve months EPS of €0.88.

PE Ratio

BARCO has a trailing twelve months price to earnings ratio of 13.53. Meaning, the purchaser of the share is investing €13.53 for every euro of annual earnings.

Volatility

BARCO’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.52%, a negative 0.06%, and a positive 1.63%.

BARCO’s highest amplitude of average volatility was 1.64% (last week), 1.34% (last month), and 1.63% (last quarter).

More news about BARCO.

3. BELYSSE GROUP (BELYS.BR)

6.96% Price Change

Belysse Group NV engages in the production and sale of textile floor coverings for commercial and residential applications in Europe, North America, and internationally. The company designs, manufactures, and distributes broadloom carpets and modular carpet tiles for offices and public projects. It commercializes its products under the Bentley, modulyss, arc edition, and ITC brands. The company was formerly known as Balta Group NV and changed its name to Belysse Group NV in October 2022. Belysse Group NV was founded in 1964 and is headquartered in Waregem, Belgium. Belysse Group NV is a subsidiary of LSF9 Belysse Holdco S.à r.l.

BEL 20 ended the session with BELYSSE GROUP rising 6.96% to €0.85 on Wednesday while BEL 20 rose 0.28% to €4,017.59.

Earnings Per Share

As for profitability, BELYSSE GROUP has a trailing twelve months EPS of €-0.31.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BELYSSE GROUP’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for BELYSSE GROUP is 420 which is 94.78% below its average volume of 8049.

More news about BELYSSE GROUP.

4. ELLIPTIC LABORATOR (ELABS.OL)

5.99% Price Change

Elliptic Laboratories ASA, an artificial intelligence (AI) software company, engages in the provision of AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive industries in Norway, the United States, China, South Korea, Taiwan, and Japan. The company offers AI Virtual Human Presence Sensor, a presence-detection solution used to improve the security of data stored on devices and to allow intuitive responses based on natural human interaction; AI Virtual Proximity Sensor that enables exquisite full-screen devices; and AI Virtual Connection Sensor that allows to pair and authenticate smart devices in the same room. It also provides AI Virtual Position Sensor which automatically detects the location of an external display in relation to a laptop; AI Virtual Gesture Sensor, a touch-free ultrasound gesture technology, that enables touchless user interactions; AI Virtual Breathing sensor that enables to track person's breathing; and AI Virtual heart Sensor that tracks a person's heart rate. The company was incorporated in 2006 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ELLIPTIC LABORATOR rising 5.99% to €13.44 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.45% to €1,431.74.

Earnings Per Share

As for profitability, ELLIPTIC LABORATOR has a trailing twelve months EPS of kr-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.11%.

Moving Average

ELLIPTIC LABORATOR’s worth is way under its 50-day moving average of kr15.84 and way under its 200-day moving average of kr16.12.

More news about ELLIPTIC LABORATOR.

5. OKEA (OKEA.OL)

5.69% Price Change

OKEA ASA, an oil and gas company, engages in the development and production of oil and gas in the Norwegian Continental Shelf. It holds 44.56% interests in Draugen, 35.2% interests in Brage, 12% interests in Gjøa, 9.2385% interests in Ivar Aasen, 15% interests in Yme, and 6% interests in Nova. The company was incorporated in 2015 and is headquartered in Trondheim, Norway.

Oslo Børs Benchmark Index_GI ended the session with OKEA jumping 5.69% to €23.78 on Wednesday while Oslo Børs Benchmark Index_GI rose 0.45% to €1,431.74.

Earnings Per Share

As for profitability, OKEA has a trailing twelve months EPS of kr-11.66.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -84.19%.

Volatility

OKEA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.18%, a negative 0.14%, and a positive 1.53%.

OKEA’s highest amplitude of average volatility was 1.62% (last week), 1.76% (last month), and 1.53% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 16.8%, now sitting on 9.23B for the twelve trailing months.

More news about OKEA.

6. BEWI (BEWI.OL)

5.41% Price Change

BEWi ASA provides packaging, components, and insulation solutions in Norway and internationally. The company operates through RAW, Insulation & Construction (I&C), Packaging & Components (P&C), and Circular segments. The RAW segment produces raw materials, including white and grey expanded polystyrene, and general purpose polystyrene, as well as BioFoam, a bio-based particle foam. The I&C segment develops and manufactures a range of solutions for insulation products for the building and construction industry; and insulation boards from polyisocyanurate and mineral wool sandwich panels. The P&C segment manufactures and sells standard and customised packaging solutions, as well as technical and automotive components for various industrial sectors; and trades products related to food packaging. The Circular segment has a wide offering within waste management; collects and recycles expanded polystyrene; trades used materials; produces recycled general purpose polystyrene; and re-processing of used materials. The company operates through production facilities in Norway, Sweden, Finland, Denmark, Czech Republic, Lithuania, Poland, Germany, Belgium, the Netherlands, Spain, Portugal, and in the United Kingdom; and facilities in Germany, France, Poland. The company was founded in 1980 and is headquartered in Trondheim, Norway. BEWi ASA is a subsidiary of BEWI Invest AS.

Oslo Børs Benchmark Index_GI ended the session with BEWI jumping 5.41% to €27.30 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.45% to €1,431.74, after two sequential sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, BEWI has a trailing twelve months EPS of kr-1.52.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.23%.

More news about BEWI.

7. BERGENBIO (BGBIO.OL)

5.09% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory diseases in Norway. The company's lead clinical asset is the Bemcentinib (BGB016), an inhibitor of AXL receptor tyrosine kinase (AXL), which is in phase 1b/2a clinical trial to treat non-small cell lung cancer; and (BGBC008), which is in phase 2 clinical trial to treat second-line non-small cell lung cancer (2L NSCLC). It develops Bemcentinib, which is in preclinical trial to treat acute respiratory distress syndrome; Tilvestamab (BGB149), anti-AXL monoclonal antibody, which in phase 1 clinical trial for the treatment of ovarian cancer; and Mipasetamab Uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. BerGenBio ASA was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO jumping 5.09% to €12.68 on Wednesday, after three consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.45% to €1,431.74, after two consecutive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr67.

PE Ratio

BERGENBIO has a trailing twelve months price to earnings ratio of 0.19. Meaning, the purchaser of the share is investing kr0.19 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

More news about BERGENBIO.

8. NOVABASE,SGPS (NBA.LS)

4.35% Price Change

Novabase S.G.P.S., S.A., through its subsidiaries, provides IT consulting and services in Portugal, rest of Europe, Africa, the Middle East, and internationally. It operates through two segments, Next-Gen and Value Portfolio. The Next-Gen segment develops IT consulting and services to banks, insurance, capital markets, and telecommunication industries under the Celfocus brand name. The Value Portfolio segment is involved in venture capital activities. Novabase S.G.P.S., S.A. was incorporated in 1989 and is headquartered in Lisbon, Portugal.

PSI ended the session with NOVABASE,SGPS rising 4.35% to €6.00 on Wednesday, following the last session’s downward trend. PSI fell 0.15% to €6,765.92, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, NOVABASE,SGPS has a trailing twelve months EPS of €0.11.

PE Ratio

NOVABASE,SGPS has a trailing twelve months price to earnings ratio of 54.55. Meaning, the purchaser of the share is investing €54.55 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.03%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NOVABASE,SGPS’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth grew by 16.9%, now sitting on 176.23M for the twelve trailing months.

More news about NOVABASE,SGPS.

9. ATOS (ATO.PA)

4.23% Price Change

Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, and telecommunication and media industries. The company was incorporated in 1982 and is headquartered in Bezons, France.

CAC 40 ended the session with ATOS jumping 4.23% to €1.16 on Wednesday while CAC 40 dropped 0.12% to €7,570.81.

Earnings Per Share

As for profitability, ATOS has a trailing twelve months EPS of €-31.04.

Volume

Today’s last reported volume for ATOS is 5172000 which is 6.28% below its average volume of 5518730.

More news about ATOS.

10. VOW (VOW.OL)

4.12% Price Change

Vow ASA, together with its subsidiaries, produces, delivers, and maintains systems for processing and purifying wastewater, food waste, solid waste, and bio sludge in Norway, France, Poland, the United States, and Italy. The company operates through Industrial Solutions, Maritime Solutions, and Aftersales segments. The Industrial Solutions segment offers and designs plants for processing biomass, food products, and industry residues. The Maritime Solution segment delivers ship systems to shipyards for newbuild constructions, which include advanced wastewater purification, waste management, and food waste processing; and advanced systems to shipowners for ships. The Aftersales segment provides spare parts and consumables chemicals; and tailor-made service and maintenance programs. In addition, it offers Biogreen, a patented pyrolysis process for converting biomass, plastics, and waste into energy; Safesteril, a patented sterilisation process for food and pharmaceutical ingredients; and industrial robotics solutions, including robotic systems for waste recycling processes. Further, the company develops, designs, and fabricates industrial furnaces and equipment for heat treatment processes. It serves cruise, aquaculture, and landbased industries, as well as utilities. The company has a strategic partnership agreement with Repsol, S.A. for addressing the pressing issue of plastic waste; SAS IMPROVE for research and development of technological solutions; and Circon Energy, for equipment supply carbon refinery projects. The company was formerly known as Scanship Holding ASA and changed its name to VOW ASA in January 2020. Vow ASA was founded in 2011 and is headquartered in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with VOW rising 4.12% to €7.59 on Wednesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.45% to €1,431.74, after two sequential sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, VOW has a trailing twelve months EPS of kr-1.34.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.86%.

Volatility

VOW’s last week, last month’s, and last quarter’s current intraday variation average was 1.46%, 0.97%, and 3.04%.

VOW’s highest amplitude of average volatility was 2.71% (last week), 2.66% (last month), and 3.04% (last quarter).

Volume

Today’s last reported volume for VOW is 227631 which is 101.26% above its average volume of 113101.

More news about VOW.

Losers Today

1. COFINA,SGPS (CFN.LS)

-14.88% Price Change

Cofina, SGPS, S.A., through its subsidiaries, engages in the publication of newspapers and magazines in Portugal. The company offers newspapers, including Correio da Manha, a daily newspaper; Record, a daily sport newspaper; Negocios, an economic newspaper; and Destak, a free newspaper. It also provides Sábado, an entertainment weekly magazine; TV Guia, weekly television magazine; Máxima, an online publication that develops topics related to culture, fashion, beauty, health and well-being, and travel and lifestyle; Flash, an online publication which addresses the social current affairs of national and international public figures; and Correio da Manhã TV (cmTV), a cable platform. In addition, the company engages in the investment management activities. The company was incorporated in 1990 and is headquartered in Porto, Portugal.

PSI ended the session with COFINA,SGPS sliding 14.88% to €0.65 on Wednesday while PSI dropped 0.15% to €6,765.92.

Earnings Per Share

As for profitability, COFINA,SGPS has a trailing twelve months EPS of €-1.4.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on May 17, 2023, the estimated forward annual dividend rate is 0.03 and the estimated forward annual dividend yield is 6.48%.

Volume

Today’s last reported volume for COFINA,SGPS is 442011 which is 284.47% above its average volume of 114966.

More news about COFINA,SGPS.

2. NEL (NEL.OL)

-8.43% Price Change

Nel ASA, a hydrogen company, provides various solutions to produce, store, and distribute hydrogen from renewable energy in Norway and internationally. The company operates in two segments, Nel Hydrogen Fueling and Nel Hydrogen Electrolyser. The Nel Hydrogen Fueling segment manufactures hydrogen fueling stations for fuel cell electric vehicles, such as cars, buses, trucks, and other on-road vehicles. The Nel Hydrogen Electrolyser segment supplies hydrogen production equipment based on alkaline and proton exchange membrane water electrolysis technology. It serves industries, energy, and gas companies. The company was formerly known as DiaGenic ASA and changed its name to Nel ASA in October 2014. Nel ASA was founded in 1927 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NEL falling 8.43% to €6.21 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.45% to €1,431.74.

Earnings Per Share

As for profitability, NEL has a trailing twelve months EPS of kr-0.41.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.47%.

Moving Average

NEL’s value is below its 50-day moving average of kr6.26 and under its 200-day moving average of kr6.23.

Sales Growth

NEL’s sales growth for the current quarter is negative 4.1%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 14%, now sitting on 1.73B for the twelve trailing months.

More news about NEL.

3. ASML HOLDING (ASML.AS)

-8.38% Price Change

ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems for chipmakers. It offers advanced semiconductor equipment systems, including lithography, metrology, and inspection systems. The company also provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. In addition, it offers metrology and inspection systems, including YieldStar optical metrology systems to assess the quality of patterns on the wafers; and HMI electron beam solutions to locate and analyze individual chip defects. Further, the company provides computational lithography solutions, and lithography systems and control software solutions; and refurbishes and upgrades lithography systems, as well as offers customer support and related services. It operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.

AEX-Index ended the session with ASML HOLDING falling 8.38% to €895.90 on Wednesday, after two consecutive sessions in a row of losses. AEX-Index slid 1.81% to €916.54, after two successive sessions in a row of losses, on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, ASML HOLDING has a trailing twelve months EPS of €18.09.

PE Ratio

ASML HOLDING has a trailing twelve months price to earnings ratio of 49.52. Meaning, the purchaser of the share is investing €49.52 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.28%.

Volume

Today’s last reported volume for ASML HOLDING is 610945 which is 31.27% above its average volume of 465403.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ASML HOLDING’s stock is considered to be overbought (>=80).

Sales Growth

ASML HOLDING’s sales growth is negative 12.6% for the present quarter and 15.1% for the next.

Yearly Top and Bottom Value

ASML HOLDING’s stock is valued at €895.90 at 22:40 EST, way under its 52-week high of €1,021.80 and way above its 52-week low of €534.40.

More news about ASML HOLDING.

4. ATLANTIC SAPPHIRE (ASA.OL)

-6.22% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the production and sale of land-based salmon in Denmark and the United States. The company was incorporated in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE dropping 6.22% to €4.75 on Wednesday, after four sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.45% to €1,431.74, after two sequential sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-37.6.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Yearly Top and Bottom Value

ATLANTIC SAPPHIRE’s stock is valued at kr4.75 at 22:40 EST, way below its 52-week high of kr20.36 and above its 52-week low of kr4.50.

Volume

Today’s last reported volume for ATLANTIC SAPPHIRE is 523226 which is 131.61% above its average volume of 225905.

More news about ATLANTIC SAPPHIRE.

5. SALMONES CAMANCHAC (SACAM.OL)

-6.03% Price Change

Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic and Coho salmon products in various formats, such as whole, fillet, portion, and other products including bits and pieces, harasu, and scrape meat. It also exports its products. Salmones Camanchaca S.A. was incorporated in 2009 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A. is a subsidiary of Camanchaca S.A.

Oslo Børs Benchmark Index_GI ended the session with SALMONES CAMANCHAC dropping 6.03% to €21.80 on Wednesday, after three successive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.45% to €1,431.74, after two consecutive sessions in a row of losses, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, SALMONES CAMANCHAC has a trailing twelve months EPS of kr-2.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.32%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 3.56 and the estimated forward annual dividend yield is 14.72%.

More news about SALMONES CAMANCHAC.

6. ASM INTERNATIONAL (ASM.AS)

-5.61% Price Change

ASM International NV, together with its subsidiaries, engages in the research, development, manufacture, marketing, and servicing of equipment and materials used to produce semiconductor devices in Europe, the United States, and Asia. The company's products include wafer processing deposition systems for atomic layer deposition (ALD), epitaxy, silicon carbide, plasma enhanced chemical vapor deposition (PECVD), and vertical furnace systems, including low pressure chemical vapor deposition (LPCVD), diffusion, and oxidation products, as well as provides spare parts and support services. It also manufactures and sells equipment, which is used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. The company offers its products to semiconductor manufacturers. The company was formerly known as Advanced Semiconductor Materials International NV. ASM International NV was incorporated in 1968 and is headquartered in Almere, the Netherlands.

AEX-Index ended the session with ASM INTERNATIONAL sliding 5.61% to €693.60 on Wednesday while AEX-Index dropped 1.81% to €916.54.

Earnings Per Share

As for profitability, ASM INTERNATIONAL has a trailing twelve months EPS of €11.02.

PE Ratio

ASM INTERNATIONAL has a trailing twelve months price to earnings ratio of 62.94. Meaning, the purchaser of the share is investing €62.94 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.73%.

Yearly Top and Bottom Value

ASM INTERNATIONAL’s stock is valued at €693.60 at 22:40 EST, below its 52-week high of €748.00 and way above its 52-week low of €354.30.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 5.2% and 25.3%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth declined by 10%, now sitting on 2.56B for the twelve trailing months.

Sales Growth

ASM INTERNATIONAL’s sales growth is 2.5% for the ongoing quarter and 18% for the next.

More news about ASM INTERNATIONAL.

7. VIVORYON (VVY.AS)

-5.03% Price Change

Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.

AEX-Index ended the session with VIVORYON sliding 5.03% to €2.08 on Wednesday while AEX-Index slid 1.81% to €916.54.

Earnings Per Share

As for profitability, VIVORYON has a trailing twelve months EPS of €-1.12.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -107.38%.

Moving Average

VIVORYON’s value is way above its 50-day moving average of €1.71 and way under its 200-day moving average of €5.32.

Volatility

VIVORYON’s last week, last month’s, and last quarter’s current intraday variation average was 1.19%, 0.54%, and 9.08%.

VIVORYON’s highest amplitude of average volatility was 1.65% (last week), 6.03% (last month), and 9.08% (last quarter).

Yearly Top and Bottom Value

VIVORYON’s stock is valued at €2.08 at 22:40 EST, way below its 52-week high of €14.10 and way higher than its 52-week low of €0.41.

Volume

Today’s last reported volume for VIVORYON is 184930 which is 84.82% below its average volume of 1218790.

More news about VIVORYON.

8. INTEROIL EXPL PROD (IOX.OL)

-4.96% Price Change

Interoil Exploration and Production ASA, together with its subsidiaries, operates as an upstream oil exploration and production company in Argentina and Colombia. It engages in the acquisition, exploration, development, and operation of oil and natural gas properties. The company's portfolio includes two producing concessions and two exploration concessions in Colombia; and one exploration and seven production concessions in Argentina. Interoil Exploration and Production ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with INTEROIL EXPL PROD dropping 4.96% to €4.91 on Wednesday, after five successive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.45% to €1,431.74, after two successive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, INTEROIL EXPL PROD has a trailing twelve months EPS of kr0.03.

PE Ratio

INTEROIL EXPL PROD has a trailing twelve months price to earnings ratio of 163.5. Meaning, the purchaser of the share is investing kr163.5 for every norwegian krone of annual earnings.

Moving Average

INTEROIL EXPL PROD’s worth is below its 50-day moving average of kr5.03 and under its 200-day moving average of kr4.95.

More news about INTEROIL EXPL PROD.

9. EBUSCO HOLDING (EBUS.AS)

-4.93% Price Change

Ebusco Holding N.V., together with its subsidiaries, engages in the development, manufacture, and distribution of zero emission buses and charging systems. It also provides ancillary products and services to electric vehicle ecosystem; and manufactures and supplies energy storage systems and mobile energy containers, as well as repair and maintenance services. The company operates in the Netherlands, Belgium, France, Germany, Norway, Switzerland, and Denmark. Ebusco Holding N.V. was founded in 2010 and is headquartered in Deurne, the Netherlands.

AEX-Index ended the session with EBUSCO HOLDING dropping 4.93% to €1.35 on Wednesday while AEX-Index fell 1.81% to €916.54.

Earnings Per Share

As for profitability, EBUSCO HOLDING has a trailing twelve months EPS of €-2.01.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.19%.

Volatility

EBUSCO HOLDING’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.05%, a negative 2.75%, and a positive 3.04%.

EBUSCO HOLDING’s highest amplitude of average volatility was 3.05% (last week), 4.32% (last month), and 3.04% (last quarter).

More news about EBUSCO HOLDING.

10. HOLLAND COLOURS (HOLCO.AS)

-4.76% Price Change

Holland Colours N.V., together with its subsidiaries, manufactures, distributes, and sells color concentrates in Europe, North America, Asia, and internationally. The company offers colorants for the building and construction industry, including profiles, pipes, tubing and fittings, siding and cladding, decking, fencing, window blinds, and insulation, as well as solutions for a range of polymers. It offers colorants for packaging applications comprising water, carbonated soft drinks, fruit juices, dairy, beer, wine, detergents, pharmaceutical, and personal care products. In addition, the company offers v, sealants, or adhesives; and colorants for other applications, such as shopping bags, polybags, mulch films, OPP tapes, PU flexible foams, synthetic leather, fiber glass and buttons, paving blocks, artificial stones, cast PMMA, PP non-woven and spunbond, coatings, flexible PVCs, prosthetics, glass fiber reinforced nylon, and silicone rubber and elastomers. It sells its products through a network of suppliers, agents, and distributors. The company was founded in 1979 and is headquartered in Apeldoorn, the Netherlands. Holland Colours N.V. operates as a subsidiary of Holland Pigments BV.

AEX-Index ended the session with HOLLAND COLOURS sliding 4.76% to €90.00 on Wednesday while AEX-Index dropped 1.81% to €916.54.

Earnings Per Share

As for profitability, HOLLAND COLOURS has a trailing twelve months EPS of €6.02.

PE Ratio

HOLLAND COLOURS has a trailing twelve months price to earnings ratio of 14.95. Meaning, the purchaser of the share is investing €14.95 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.62%.

More news about HOLLAND COLOURS.

Stay up to date with our winners and losers daily report